Companies / Matter Bio
Matter Bio
Company
Matter Bio has developed a clinical-stage next generation immuno-oncology platform designed to recruit memory T cells into the hardest-to-treat solid tumors.
Matter Bio has 1 investor on file, among them quadraScope Ventures.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
More from quadraScope Ventures
12 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See quadraScope Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Matter Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when quadraScope Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/matterbio.com/investors
# also
GET /v1/companies/matterbio.com
GET /v1/companies/matterbio.com/news